Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients.

Chaaban N, Kastrup J, Qayyum AA

Open source

DOI
10.1080/17460751.2025.2574194
Published
2025 Nov
Container
Regenerative medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17460751.2025.2574194,
  title = {Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients.},
  author = {Chaaban N and Kastrup J and Qayyum AA},
  year = {2025},
  journal = {Regenerative medicine},
  doi = {10.1080/17460751.2025.2574194},
  url = {https://doi.org/10.1080/17460751.2025.2574194}
}

RIS

TY  - JOUR
TI  - Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients.
AU  - Chaaban N
AU  - Kastrup J
AU  - Qayyum AA
PY  - 2025
JO  - Regenerative medicine
DO  - 10.1080/17460751.2025.2574194
UR  - https://doi.org/10.1080/17460751.2025.2574194
ER  - 

APA

N, C., J, K., & AA, Q. (2025). Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients.. Regenerative medicine. https://doi.org/10.1080/17460751.2025.2574194

Source records